Can tuberculosis be controlled?

被引:21
作者
Frieden, TR
机构
[1] WHO, Reg Off SE Asia, New Delhi, India
[2] Ctr Dis Control & Prevent, Atlanta, GA USA
[3] Columbia Univ, Sch Publ Hlth, New York, NY USA
关键词
tuberculosis; short-course chemotherapy; disease control; burden of disease;
D O I
10.1093/ije/31.5.894
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Tuberculosis (TB) is nearly 100% curable. However, the ability of medical and public health interventions to control TB, particularly in developing countries, is often doubted Methods We reviewed data for the amenability of TB to control. We considered separately control of deaths, prevalence, rate of infection and incidence. Results Tuberculosis mortality can be reduced by more than 80% in less than 5 years. The prevalence of TB can be reduced by 30% or more annually; sustained annual decreases of 17% have been documented in a developing country. The TB infection rate can be reduced by 15% annually. In the absence of human immunodeficiency virus (HIV), TB incidence can be decreased by as much as 25% per year and up to 10% annually in developing countries. A high prevalence of untreated HIV infection in the adult population of a developing country will inevitably result in a significant increase in TB incidence despite optimal use of currently available technologies. Conclusions Tuberculosis can be controlled if appropriate policies are followed, effective clinical and public health management is ensured, and there are committed and co-ordinated efforts from within and outside the health sector. However, in the context of a large epidemic of AIDS, TB incidence will inevitably increase. By 2001, less than 30% of global TB cases were reported to have received effective diagnosis, treatment and monitoring. Rapid expansion of effective TB control services is urgently required, both to avert the continued high burden of morbidity and mortality from TB and because of the HIV pandemic.
引用
收藏
页码:894 / 899
页数:6
相关论文
共 40 条
[1]  
[Anonymous], B INT UNION TUBERC
[2]  
[Anonymous], 1997, TREATM TUB GUID NAT
[3]   RESURGENT TUBERCULOSIS IN NEW-YORK-CITY - HUMAN-IMMUNODEFICIENCY-VIRUS, HOMELESSNESS, AND THE DECLINE OF TUBERCULOSIS-CONTROL PROGRAMS [J].
BRUDNEY, K ;
DOBKIN, J .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (04) :745-749
[4]   Tuberculosis in sub-Saharan Africa: A regional assessment of the impact of the human immunodeficiency virus and National Tuberculosis Control Program quality [J].
Cantwell, MF ;
Binkin, NJ .
TUBERCLE AND LUNG DISEASE, 1996, 77 (03) :220-225
[5]   CRITICAL-ASSESSMENT OF SMEAR-POSITIVE PULMONARY TUBERCULOSIS PATIENTS AFTER CHEMOTHERAPY UNDER THE DISTRICT TUBERCULOSIS PROGRAM [J].
DATTA, M ;
RADHAMANI, MP ;
SELVARAJ, R ;
PARAMASIVAN, CN ;
GOPALAN, BN ;
SUDEENDRA, CR ;
PRABHAKAR, R .
TUBERCLE AND LUNG DISEASE, 1993, 74 (03) :180-186
[6]  
Diaz R, 1998, INT J TUBERC LUNG D, V2, P743
[7]  
Dye C, 2000, INT J TUBERC LUNG D, V4, pS146
[8]   Evaluating the impact of tuberculosis control: number of deaths prevented by short-course chemotherapy in China [J].
Dye, C ;
Zhao, FZ ;
Scheele, S ;
Williams, B .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2000, 29 (03) :558-564
[9]   THE EMERGENCE OF DRUG-RESISTANT TUBERCULOSIS IN NEW-YORK-CITY [J].
FRIEDEN, TR ;
STERLING, T ;
PABLOSMENDEZ, A ;
KILBURN, JO ;
CAUTHEN, GM ;
DOOLEY, SW .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (08) :521-526
[10]   TUBERCULOSIS-CONTROL AND SOCIAL-CHANGE [J].
FRIEDEN, TR .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1994, 84 (11) :1721-1723